Additionally, DOK3 has been shown to regulate junction proteins in tyrosine kinase signaling feedback loops and inhibit oncogenic pathways mediated by protein tyrosine kinases (PTKs), which are implicated in tumor development and progression. Here, DOK3 is linked to neoplasm.